£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

CML Treatment Outlook 2023-2028 - US Zip Code Analysis

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 26 days · 26 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 09 August 2026 15 August 2026 21 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 65 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 26 days • 1 price levels

Days at Price
26 days 0 7 13 20 26 £490 Days at Price

Price Analysis

Most common price: £490 (26 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 26 days

Description

This specialized study provides a detailed outlook for chronic myelogenous leukemia (CML) treatments across the United States from 2023 to 2028. It focuses on latent demand, measured in millions of U.S. dollars, also known as potential industry earnings (P.I.E.). The data covers 10,833 specific zip codes, offering a granular view of market opportunities. For every zip code analyzed, the report includes the percent share relative to both its specific state and the United States as a whole. These comparative benchmarks allow users to quickly evaluate the value of one zip code against others. This statistical approach serves as a valuable resource for optimizing distribution strategies and managing sales force deployment effectively.

Key Features

Covers latent demand and potential industry earnings for CML treatments from 2023 through 2028.

Provides detailed data across 10,833 individual zip codes throughout the United States.

Includes percent share metrics for each zip code compared to its state and the entire country.

Offers comparative benchmarks to help gauge the value of specific zip codes against others.

Supports strategic planning for distribution and sales force management through statistical analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
26 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
97% match

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

£495.00 31 Oct 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 22 Aug 2026
Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook
97% match

Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan

£495.00 20 Aug 2026
Myeloid Leukemia: Clinical Diagnosis and Treatment Guide
97% match

Myeloid Leukemia: Clinical Diagnosis and Treatment Guide

IntechOpen

£129.16 09 Oct 2026
Myeloid Leukemia: Methods and Protocols - Medical Research Guide
96% match

Myeloid Leukemia: Methods and Protocols - Medical Research Guide

Humana

£103.66 20 Oct 2026
Hematology and Oncology Products in Europe Outlook 2016-2021
96% match

Hematology and Oncology Products in Europe Outlook 2016-2021

£425.00 20 Aug 2026
Chronic Myeloid Leukemia (Hematologic Malignancies)
96% match

Chronic Myeloid Leukemia (Hematologic Malignancies)

Springer

£81.74 11 Sep 2026
Hematology and Oncology Products Outlook 2016-2021 Report
96% match

Hematology and Oncology Products Outlook 2016-2021 Report

£425.00 20 Aug 2026
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
96% match

The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics

Price unavailable
Hematology and Oncology Products in Asia Outlook Report
96% match

Hematology and Oncology Products in Asia Outlook Report

£425.00 20 Aug 2026
Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028
96% match

Non-Hodgkin and Chronic Lymphoma Treatment Outlook 2023-2028

£490.00 28 Aug 2026
Middle East Hematology and Oncology Market Outlook 2016-2021
96% match

Middle East Hematology and Oncology Market Outlook 2016-2021

£425.00 21 Aug 2026
Hematology and Oncology Products in Africa Outlook 2016-2021
96% match

Hematology and Oncology Products in Africa Outlook 2016-2021

£425.00 21 Aug 2026
The 2023-2028 World Outlook for Hematologic Malignancies
96% match

The 2023-2028 World Outlook for Hematologic Malignancies

Price unavailable
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
96% match

The 2016-2021 Outlook for Hematology and Oncology Products in Greater China

£595.00 01 Oct 2026
The 2021-2026 World Outlook for Hematology and Oncology Products
96% match

The 2021-2026 World Outlook for Hematology and Oncology Products

£795.00 20 Aug 2026
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America (Volume 39-5) (The Clinics: Internal Medicine, Volume 39-5)
96% match

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America (Volume 39-5) (The Clinics: Internal Medicine, Volume 39-5)

Elsevier

£75.36 23 Sep 2026
Hematology and Oncology Products Outlook in Oceana Book
96% match

Hematology and Oncology Products Outlook in Oceana Book

£425.00 21 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
96% match

The 2016-2021 Outlook for Hematology and Oncology Products in the United States

£595.00 18 Sep 2026
The 2016-2021 Outlook for Hematology and Oncology Products in India
96% match

The 2016-2021 Outlook for Hematology and Oncology Products in India

£595.00 22 Aug 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in China

£495.00 22 Aug 2026
The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Lymphoma Treatments for US Zip Codes

£490.00 28 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Japan
96% match

The 2016-2021 Outlook for Hematology and Oncology Products in Japan

£595.00 21 Aug 2026